An AllTrials project

NCT03883945: An ongoing trial by Aiviva BioPharma Inc.

This trial is ongoing. It must report results 2 years, 4 months from now.

Full data

Full entry on ClinicalTrials.gov NCT03883945
Title A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Intradermally Administered AIV001 in Subjects With Papulopustular Rosacea
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Dec. 31, 2020
Completion date Dec. 31, 2021
Required reporting date Dec. 31, 2022, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov July 30, 2020
Days late None